Company / Depreciation & Amortization
Atara Biotherapeutics, Inc. Depreciation & Amortization History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$2.1M
FY2025
5-year range
$2.1M / $4.8M
FY2024-FY2025
Trend
-56.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$2M in FY2025.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, depreciation & amortization decreased 56.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -73.54 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.1M | -56.2% |
| FY2024 | $4.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026